Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis

Purpose: Given the poor prognosis and the relative rarity of patients diagnosed with limb rhabdomyosarcoma (LRMS) and metastasis at diagnosis, we performed this study to reveal distinctive clinical features and evaluated prognostic factors of this special population in order to provide appropriate t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chunying Yang, Haiqing Wang, Feng Niu, Lufeng Yao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6362fc55b9204d448216e6dd3fcfcfba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6362fc55b9204d448216e6dd3fcfcfba
record_format dspace
spelling oai:doaj.org-article:6362fc55b9204d448216e6dd3fcfcfba2021-11-04T05:19:09ZPopulation-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis2296-875X10.3389/fsurg.2021.738771https://doaj.org/article/6362fc55b9204d448216e6dd3fcfcfba2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fsurg.2021.738771/fullhttps://doaj.org/toc/2296-875XPurpose: Given the poor prognosis and the relative rarity of patients diagnosed with limb rhabdomyosarcoma (LRMS) and metastasis at diagnosis, we performed this study to reveal distinctive clinical features and evaluated prognostic factors of this special population in order to provide appropriate treatment.Patients and Methods: We carried out retrospective research of patients diagnosed with LRMS and metastasis from 1975 to 2016 using the Surveillance, Epidemiology, and End Results (SEER) program database. Survival curves were generated by applying the Kaplan–Meier method. In terms of evaluating and determining independent predictors of survival, we conducted univariate and multivariate survival analyses using the Cox proportional hazard regression model.Results: This retrospective analysis contained a series of 245 patients with metastatic LRMS, with male predominance (male vs. female, 1.6:1). Nearly half of the patients were diagnosed with alveolar rhabdomyosarcoma (44.9%). According to the results of the univariate and multivariate analyses, younger age, tumor subtype, and radiotherapy were found to be significantly associated with improved overall survival (OS) and cause-specific survival (CSS).Conclusions: Patients with LRMS and metastasis at diagnosis experienced a quite poor prognosis. Age at diagnosis, tumor subtype, and radiotherapy can help clinicians to better estimate the prognosis. This study indicated that local radiotherapy can provide a survival benefit.Chunying YangHaiqing WangFeng NiuLufeng YaoFrontiers Media S.A.articlelimb rhabdomyosarcoma (LRMS)metastasis at diagnosissurvival analysistumor subtyperadiotherapySurgeryRD1-811ENFrontiers in Surgery, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic limb rhabdomyosarcoma (LRMS)
metastasis at diagnosis
survival analysis
tumor subtype
radiotherapy
Surgery
RD1-811
spellingShingle limb rhabdomyosarcoma (LRMS)
metastasis at diagnosis
survival analysis
tumor subtype
radiotherapy
Surgery
RD1-811
Chunying Yang
Haiqing Wang
Feng Niu
Lufeng Yao
Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
description Purpose: Given the poor prognosis and the relative rarity of patients diagnosed with limb rhabdomyosarcoma (LRMS) and metastasis at diagnosis, we performed this study to reveal distinctive clinical features and evaluated prognostic factors of this special population in order to provide appropriate treatment.Patients and Methods: We carried out retrospective research of patients diagnosed with LRMS and metastasis from 1975 to 2016 using the Surveillance, Epidemiology, and End Results (SEER) program database. Survival curves were generated by applying the Kaplan–Meier method. In terms of evaluating and determining independent predictors of survival, we conducted univariate and multivariate survival analyses using the Cox proportional hazard regression model.Results: This retrospective analysis contained a series of 245 patients with metastatic LRMS, with male predominance (male vs. female, 1.6:1). Nearly half of the patients were diagnosed with alveolar rhabdomyosarcoma (44.9%). According to the results of the univariate and multivariate analyses, younger age, tumor subtype, and radiotherapy were found to be significantly associated with improved overall survival (OS) and cause-specific survival (CSS).Conclusions: Patients with LRMS and metastasis at diagnosis experienced a quite poor prognosis. Age at diagnosis, tumor subtype, and radiotherapy can help clinicians to better estimate the prognosis. This study indicated that local radiotherapy can provide a survival benefit.
format article
author Chunying Yang
Haiqing Wang
Feng Niu
Lufeng Yao
author_facet Chunying Yang
Haiqing Wang
Feng Niu
Lufeng Yao
author_sort Chunying Yang
title Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
title_short Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
title_full Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
title_fullStr Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
title_full_unstemmed Population-Based Survival Analysis of Patients With Limb Rhabdomyosarcoma and Metastasis at Diagnosis
title_sort population-based survival analysis of patients with limb rhabdomyosarcoma and metastasis at diagnosis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6362fc55b9204d448216e6dd3fcfcfba
work_keys_str_mv AT chunyingyang populationbasedsurvivalanalysisofpatientswithlimbrhabdomyosarcomaandmetastasisatdiagnosis
AT haiqingwang populationbasedsurvivalanalysisofpatientswithlimbrhabdomyosarcomaandmetastasisatdiagnosis
AT fengniu populationbasedsurvivalanalysisofpatientswithlimbrhabdomyosarcomaandmetastasisatdiagnosis
AT lufengyao populationbasedsurvivalanalysisofpatientswithlimbrhabdomyosarcomaandmetastasisatdiagnosis
_version_ 1718445215931432960